Pharmalot -- Reeling from product recalls that have sapped revenues and investor confidence, Johnson & Johnson last week told employees in a companywide e-mail that about half will receive 90 percent of what they would normally have received due to “mixed performance against our growth targets.” J&J employs about 114,000 people, by the way.
